Certain Types of Insulin are in short supply nationwide

Insulin Glargine Injection (Recombinant)Products Affected - Description Basaglar Tempo Pen subcutaneous injection, Lilly USA, LLC, 100 units/mL, 3 mL pen injector, 5 count, NDC 00002-8214-05 Lantus Solostar Pen subcutaneous injection, Sanofi-Aventis, 100 units/mL, 3 mL pen injector, 5 count, NDC 00088-2219-05 Semglee subcutaneous injection, Biocon, 100 units/mL, 10 mL vial, NDC 83257-0011-11 - discontinued Semglee Pen subcutaneous injection, Biocon, 100 units/mL, 3 mL pen injector, 5 count, NDC 83257-0012-33 - discontinuedReason for the ShortageBiocon discontinued Semglee vials and pens on December 31, 2025. The generic vials and pens are available. Lilly has Basaglar and Rezvoglar Kwikpens available. Lilly is discontinuing...